Accessibility: Skip TopNav
Chris Liu, Ph.D.
Chris Liu, Ph.D., Senior Research Analyst specializing in oncology at RTW Investments, LP, was appointed to Artios' Board of Directors
Format
JPEG
Source
Artios Pharma, Inc.
Downloads
Original
Large
Medium
Small